Treatment Set TS339992 is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Dermatophagoides Pteronyssinus; Dermatophagoides Farinae; Cynodon Dactylon Pollen; Iva Annua Var. Annua Pollen; Juniperus Ashei Pollen; Phleum Pratense Pollen; Ambrosia Artemisiifolia Pollen; Ulmus Americana Pollen; Acer Negundo Pollen.
Product ID | 49288-0804_604c0704-1a4c-431a-9876-de77f5f3882c |
NDC | 49288-0804 |
Product Type | Human Prescription Drug |
Proprietary Name | Treatment Set TS339992 |
Generic Name | Treatment Set Ts339992 |
Dosage Form | Injection, Solution |
Route of Administration | INTRADERMAL; SUBCUTANEOUS |
Marketing Start Date | 1986-10-31 |
Marketing Category | BLA / BLA |
Application Number | BLA102223 |
Labeler Name | Antigen Laboratories, Inc. |
Substance Name | DERMATOPHAGOIDES PTERONYSSINUS; DERMATOPHAGOIDES FARINAE; CYNODON DACTYLON POLLEN; IVA ANNUA VAR. ANNUA POLLEN; JUNIPERUS ASHEI POLLEN; PHLEUM PRATENSE POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; ULMUS AMERICANA POLLEN; ACER NEGUNDO POLLEN |
Active Ingredient Strength | 400 [AU]/mL; [AU]/mL; [BAU]/mL; g/mL; g/mL; [BAU]/mL; [AU]/mL; g/mL; g/mL |
Pharm Classes | Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [CS],Insect Proteins [CS],Allergens [CS],Allergens [CS],Insect Proteins [CS],Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [CS],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 1986-10-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1986-10-31 |
Inactivation Date | 2019-10-29 |
Ingredient | Strength |
---|---|
DERMATOPHAGOIDES PTERONYSSINUS | 400 [AU]/mL |
SPL SET ID: | e50fbed1-a782-44a7-ace6-3a0d9e4a3a8e |
Manufacturer | |
UNII |
|
Pharm Class PE | |
PHarm Class EPC | |
NUI Code |